网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
临沂地区临床CRE菌株的耐药表型与碳青霉烯酶耐药基因型的特征分析
作者:王春燕1 2  关向宏2  訾臣2  孙淑红2 
单位:1. 锦州医科大学临沂市人民医院 研究生培养基地, 辽宁 锦州 121000;
2. 临沂市人民医院 检验医学中心, 山东 临沂 276000
关键词:耐碳青霉烯类肠杆菌 耐药率 耐药基因 blaKPC基因 肺炎克雷伯菌 
分类号:R446.5
出版年·卷·期(页码):2026·54·第一期(49-55)
摘要:

目的:针对临沂地区耐碳青霉烯类肠杆菌(CRE)的临床流行病学特征展开分析,聚焦菌株分布、耐药表型及耐药基因型,为本区域感染防控与临床合理用药提供证据支持。方法:收集2023年1月至2024年9月临沂市人民医院临床分离的104株CRE菌株,综合运用病原学鉴定、药敏试验及分子生物学法对菌株进行检测分析。结果:104株CRE中以肺炎克雷伯菌(71.16%)为主,其次为大肠埃希菌(20.19%);重症监护室为CRE检出的主要科室(47.12%)。药敏结果显示,CRE菌株对厄他培南、头孢呋辛、头孢呋酯、头孢曲松、头孢噻肟以及β-内酰胺酶抑制剂复合制剂氨苄西林/舒巴坦均表现出完全耐药(耐药率100%)。mCIM和eCIM表型检测结果显示,mCIM阳性95株,阴性9株,95株mCIM阳性菌株中20株为eCIM阳性。耐药基因检测中,blaKPC基因检出率最高(65.38%),其次为blaNDM(19.23%)和blaOXA-48(5.77%)基因。结论:肺炎克雷伯菌及大肠埃希菌系临沂CRE感染优势菌种,且对多种抗菌药物耐药,blaKPCblaNDMblaOXA-48基因为核心耐药机制。临床应加强对此类易感人群的防护。

Objective: To analyze the clinical epidemiological characteristics of carbapenem-resistant Enterobacterales(CRE) in Linyi region, with a focus on strain distribution, drug resistance phenotypes and resistance genotypes, so as to provide evidence for local infection prevention and control as well as rational clinical medication use. Methods: A total of 104 clinical CRE isolates were collected from Linyi People's Hospital during January 2023 to September 2024. All strains were detected and analyzed by comprehensive application of etiological identification, antimicrobial susceptibility testing and molecular biological methods. Results: Among the 104 CRE strains, Klebsiella pneumoniae was the predominant species(71.16%), followed by Escherichia coli(20.19%). The intensive care unit was the primary department with the highest CRE detection rate(47.12%). Antimicrobial susceptibility testing results indicated that all CRE strains were completely resistant to ertapenem, cefuroxime, cefuroxime axetil, ceftriaxone, cefotaxime, and the β-lactamase inhibitor combination ampicillin/sulbactam, with a resistance rate of 100%. Results of modified carbapenem inactivation method(mCIM) and enhanced carbapenem inactivation method(eCIM) phenotypic assays indicated 95 mCIM-positive strains and 9 mCIM-negative strains, among which 20 strains were eCIM-positive among the 95 mCIM-positive isolates. For resistance gene detection, the detection rate of blaKPC gene was the highest(65.38%), followed by blaNDM(19.23%) and blaOXA-48(5.77%) genes. Conclusion: Klebsiella pneumoniae and Escherichia coli are the dominant pathogens responsible for CRE infections in Linyi region, and these strains exhibit resistance to multiple antimicrobial agents. The blaKPC,blaNDM and blaOXA-48 genes are the core resistance mechanisms. Clinical practice should prioritize enhanced protection for populations susceptible to such infections.

参考文献:

[1] 辛续丽,魏勇,张佳纯,等.耐碳青霉烯类肠杆菌目细菌耐药性及耐药基因分型[J].标记免疫分析与临床,2023,30(10):1695-1699,1800.
[2] SADER H S,CASTANHEIRA M,RYAN ARENDS S J,et al.Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia:results from 20 years of the SENTRY Antimicrobial Surveillance Program(1997-2016)[J].J Antimicrob Chemother,2019,74(6):1595-1606.
[3] 尚红,王毓三,申子瑜.全国临床检验操作规程[M].4版.北京:人民卫生出版社,2015:574-773.
[4] MAYRHOFER S,ZITZ U,BIRRU F H,et al.Comparison of the CLSI guideline and ISO/IDF standard for antimicrobial susceptibility testing of Lactobacilli[J].Microb Drug Resist,2014,20(6):591-603.
[5] BRENNAN-KROHN T,MANETSCH R,O'DOHERTY G A,et al.New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae[J].Transl Res,2020,220:14-32.
[6] 李紫璇,洪梅.碳青霉烯酶的耐药机制及检测方法的研究进展[J].中国卫生检验杂志,2023,33(6):764-768.
[7] 王磊,关月,崔佳,等.陕西某三甲医院558株耐碳青霉烯类肠杆菌临床分布及耐药性[J].中华医院感染学杂志,2021,31(23):3521-3526.
[8] 彭水华,李海霞,杨赵,等.碳青霉烯类抗菌药物的使用情况与细菌耐药的相关性分析[J].中国医药科学,2025,15(20):159-163.
[9] 时芳芳,李轶,韦慧玲,等.某医院临床分离耐碳青霉烯类肠杆菌科细菌耐药特点及耐药基因分析[J].中国消毒学杂志,2021,38(12):896-899.
[10] 陈淑娟,曾建英,胡丽娟.某院耐碳青霉烯类肠杆菌科细菌的临床特征及耐药基因分析[J].中外医学研究,2022,20(22):76-80.
[11] 王维,王林,樊清清,等.GeneXpert技术对耐碳青霉烯类肠杆菌科细菌耐药基因分析[J].宁夏医科大学学报,2020,42(12):1254-1257.
[12] 朱文俊,王彦,刘霞,等.近5年某三甲医院耐碳青霉烯类肠杆菌科细菌耐药性及分子流行病学研究[J].国际检验医学杂志,2024,45(24):3004-3009.
[13] 刘香,黄琳玲,沈红梅,等.ICU和非ICU病区CRE感染现状和危险因素分析[J].南通大学学报(医学版),2021,41(6):574-577.
[14] 许恒贵,陈祝俊,赵清贵,等.华东部分地区CRE的临床特征、耐药情况及酶型分析[J].国际检验医学杂志,2023,44(16):1962-1966.
[15] 陈亚男,刘菁,李爱民,等.304例耐碳青霉烯类肠杆菌科细菌医院感染流行病学特征与干预措施及效果[J].中华医院感染学杂志,2022,32(10):1450-1453.
[16] YONG D,TOLEMAN M A,GISKE C G,et al.Characterization of a new metallo-beta-lactamase gene,bla(NDM-1),and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India[J].Antimicrob Agents Chemother,2009,53(12):5046-5054.
[17] 侯正利,张毕明,张冉,等.长沙某医院分离226株CRE临床特征及耐药分析[J].湖南师范大学学报(医学版),2021,18(5):48-50.
[18] 宋婵婵.河南省某三甲医院耐碳青霉烯类肠杆菌科细菌耐药性及耐药基因分析[J].河南预防医学杂志,2022,33(7):541-543.
[19] 陈幕,张焕棕.碳青霉烯类耐药肠杆菌目细菌的耐药性及基因型分布与流行病学分析[J].当代医学,2021,27(35):15-17.
[20] 俞凤,杨军平,金桂林,等.耐碳青霉烯类肠杆菌科细菌耐药基因及分子特征研究[J].江西中医药大学学报,2023,35(2):89-94.
[21] ZHU X,GUO C,XU S,et al.Clinical distribution of carbapenem genotypes and resistance to ceftazidime-avibactam in Enterobacteriaceae bacteria[J].Front Cell Infect Microbiol,2024,14:1345935.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 1079352 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058541